NEW YORK, August 7, 2013 /PRNewswire/ --
Today, Investors' Reports announced new research reports highlighting ResMed Inc. (NYSE: RMD), Sirona Dental Systems, Inc. (NASDAQ: SIRO), Align Technology, Inc. (NASDAQ: ALGN), ABIOMED, Inc. (NASDAQ: ABMD), and Globus Medical, Inc. (NYSE: GMED). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
ResMed Inc. Research Report
On August 1, 2013, ResMed, Inc. (ResMed) reported financial results for Q4 FY 2013 and full-year FY 2013. The Company's Q4 FY 2013 revenue was $414.6 million, up 11.5% YoY. Q4 FY 2013 non-GAAP operating income was $110.9 million, up 23.6% YoY, while non-GAAP net income was $90.7 million, up 18.1% YoY. Non-GAAP diluted EPS were $0.62, up 17.0% YoY. For full-year FY 2013, the Company generated revenues of $1.5 billion, up 10.7% YoY; non-GAAP operating income of $379.6 million, up 28.9% YoY; and non-GAAP diluted EPS of $2.22, up 29.8% YoY. Commenting on the results, Mick Farrell, CEO of ResMed said, "In the fourth quarter of fiscal 2013 we showed strong year-over-year growth on both top and bottom lines. We have also announced today that our quarterly dividend has increased by 47% to $0.25 per share. Additionally, during the quarter, we repurchased 1.5 million shares, at a cost of $72.7 million." The Full Research Report on ResMed Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.investorsreports.com/report/2013-08-05/RMD]-- Sirona Dental Systems, Inc. Research Report On August 2, 2013, Sirona Dental Systems, Inc. (Sirona) announced that its Board of Directors has unanimously approved a succession plan for the CFO of the Company. The Company informed that Ulrich Michel will be joining Sirona as its CFO and Executive Vice President, effective October 14, 2013, and will be succeeding Simone Blank, who will step down as CFO, Executive Vice President, and Board member of the Company. According to Sirona, Michel will be responsible for overseeing and directing all aspects of the financial management of the Company as its CFO and Executive Vice President. Prior to joining Sirona, Michel was the CFO of WABCO for over eight years. The Full Research Report on Sirona Dental Systems, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [ http://www.investorsreports.com/report/2013-08-05/SIRO] --